OBI Pharma, Inc.
- Biotech or pharma, therapeutic R&D
- Academic, tech transfer
OBI Pharma is developing novel ADCs powered by our proprietary ADC technologies, including OBI-992 (TROP2), OBI-902 (TROP2), OBI-904 (Nectin 4) and OBI-905 (HER2). GlycOBI® and ThiOBI® are OBI's proprietary ADC technologies for license.
*Please no service provider requests*
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}